Top compounds associated with response to CCDC110

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	COL-3	CTRPv2	pan-cancer	AAC	-0.0082	0.8
mRNA	CD-1530	CTRPv2	pan-cancer	AAC	0.0082	0.8
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0073	0.8
mRNA	GW-405833	CTRPv2	pan-cancer	AAC	0.007	0.8
mRNA	rigosertib	CTRPv2	pan-cancer	AAC	0.0066	0.8
mRNA	Lisitinib	GDSC1000	pan-cancer	AAC	0.0068	0.8
mRNA	BMS-509744	GDSC1000	pan-cancer	AAC	-0.01	0.8
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0063	0.8
mRNA	AZD4547	CTRPv2	pan-cancer	AAC	-0.0074	0.8
mRNA	TAE684	CCLE	pan-cancer	AAC	-0.0088	0.8

Download CSV